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Background: Obesity is today’s principal neglected public health problem, as a rising proportion 
of adults will succumb to the medical complications of obesity. However, little is known about 
the burden of obesity in adults living in Ontario.
Objectives: To present an overview of the human and economic burden associated with BMI 
categories in Ontario, Canada, in terms of socio-demographics, comorbidities, health-related 
quality of life (HRQoL) and costs associated with hospitalization, same day procedures and 
physician visits.
Methods: The records of all Ontarians who participated in the Canadian Community 
Health Survey (CCHS), cycle 1.1 and provided consent to data linkage were linked to three 
administrative databases. Socio-demographic variables, medical characteristics, HRQoL, one year 
hospitalization, day procedure and physician costs were described per BMI category. Regression 
analyses were conducted to identify predictors of medical characteristics, HRQoL and costs.
Results: More than 50% of adult participants were either overweight or obese in 2000/2001. 
Obese adults, and to a lesser extent overweight adults, were more likely to report physician-
diagnosed comorbid conditions, to use medications, and to have a lower HRQoL. After covariate 
adjustment, the hospitalization and physician costs were respectively 40% and 22% higher among 
obese and overweight adults than among normal-weight adults. No statistical cost differences 
were observed between normal and underweight individuals or between normal and overweight 
individuals. HRQoL was significantly lower in underweight and obese adults when compared 
to normal-weight individuals.
Conclusions: Due to the large human and economic burden associated with under- or excess-
weight, policies promoting healthy weight should remain a priority for governments and 
employers.
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Introduction
Over the last two decades, several studies have documented the economic burden 
of overweight and obesity in Canada. The direct costs of overweight (Body Mass 
Index [BMI] 25–29 kg/m2) and obesity (BMI $ 30 kg/m2) in 2006 were estimated at 
approximately $2 billion and $4 billion respectively (all values are Canadian dollars), 
a figure that represents 4.1% of the total healthcare expenditure in Canada. Indirect 
costs accounted for $5 billion.1 While this study or other similar Canadian burden of 
illness studies using national accounts2,3 provide valuable information, these studies 
did not provide a breakdown of health care utilization/medical costs per BMI or any 
information on the human burden associated with obesity (eg, health status, health-
related quality of life [HRQoL]).ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
22
Tarride et al
Using a different approach, the physician costs associated 
with overweight and obesity in Ontario have been documented 
by linking a population health survey with physician billings.4 
Compared to women and men with a normal body weight, 
annual physician costs were found to be 18% higher in obese 
women ($682 versus $577) and 15% higher in obese men 
($475 versus $414). No differences in physician costs were 
observed between normal-weight adults and overweight 
adults. Although this study provided an estimate of the 
physician costs per BMI level in Ontario using patient-level 
data, it is currently unknown whether costs associated with 
hospitalizations or day procedures differ between BMI levels. 
This is important as hospital costs represent an important 
component of healthcare costs. Again, this study did not 
present any information on the medical characteristics and 
the HRQoL of this population, thus offering an incomplete 
picture of the burden of obesity in Ontario. While other 
Canadian studies have shown that obese individuals were 
more likely to have medical conditions, to report a worse 
HRQoL than normal-weight individuals and to consume 
more medical resources,5–7 these studies were limited as 
they did not include the elderly6 or all BMI   categories 
(eg, overweight).7 There is also a lack of data on the Canadian 
costs associated with being underweight.8
To provide a broader assessment of differences between 
BMI categories, the objectives of this study were to describe 
the Ontario adult population per BMI category (eg, socio-
demographic variables, HRQoL and costs) and to determine 
whether BMI levels were predictors of individuals’ medical 
characteristics, HRQoL and costs including physician costs. 
By linking population survey and administrative data, this 
study improves on previous Canadian studies as it presents 
a detailed assessment of the human (HRQoL) and economic 
(eg, inpatient costs) burden associated with different BMI 
categories in Ontario. It also presents new and previously 
unavailable information on the health status associated with 
BMI (eg, HRQoL and cost data on underweight patients) and 
on the day procedure and hospitalization costs associated 
with BMI categories in adults living in Ontario.
Materials and methods
study population and setting
This study included records of all Ontarians older than 
18 years of age who participated in the Canadian Community 
Health Survey (CCHS), cycle 1.1 (2000/2001) and provided 
consent to data linkage with administrative databases. 
Three administrative databases were used to document the 
costs associated with hospitalizations, day procedures and 
physicians’ services in Ontario. The Discharge Abstract 
Database (DAD), Inpatient (DAD-IP) and DAD-Day 
Procedure (DAD-DP) were used for hospitalizations (inpatient 
acute, chronic and rehabilitation care) and day procedures. 
These databases are maintained by the Canadian Institute 
of Health Information (CIHI) and provide patient-level 
information on patient (eg, age) and admission (eg, length 
of stay) characteristics. The Ontario Health Insurance 
Program (OHIP) database was used to identify all claims 
made by physicians paid through fee-for-service mechanisms 
(approximately 95% of all Ontario physicians) and for 
diagnostic or laboratory tests conducted outside of hospitals. 
OHIP is maintained by the Ontario Ministry of Health and 
Long-Term Care (MOHLTC), which provided three fiscal 
years of data (1999/2000, 2000/2001 and 2001/2002). 
The record linkage between CCHS and the administrative 
databases was conducted by Statistics Canada.
survey data
The BMI calculated by Statistics Canada (excluding preg-
nant women) was used to classify respondents according to 
their self-reported BMI: underweight (BMI ,18.5 kg/m2); 
normal-weight (18.5 # BMI ,24.9 kg/m2); overweight 
(25 # BMI , 29.9 kg/m2; and obese (BMI $ 30 kg/m2). Using 
self-reported information from CCHS 1.1, the population 
was described by BMI levels in terms of socio-  demographic 
(eg, age) and medical characteristics (eg, comorbid conditions) 
as well as by health status (excellent, very good, good, fair 
and poor health) and Health Utility Index (HUI) score.9 While 
negative values can be observed, the HUI score generally 
ranges from 0 to 1 where 0 represents death and 1 represents 
being in excellent health. The HUI scores calculated by 
Statistics Canada were used in the analyses.
Administrative data
The administrative databases linked to CCHS data were 
used to estimate the costs associated with hospitalizations, 
day procedures and physician use for each BMI category. 
Using DAD-IP, inpatient hospital stays were assigned cost 
values using the resource intensity weight (RIW) (a standard 
costing methodology developed by CIHI) recorded for 
each admission which was multiplied by the average cost 
per RIW. The same approach was applied to same day 
procedures using DAD-DP. The OHIP database was used 
to identify the costs associated with physicians and non-
hospital laboratories. The cost data analysis was conducted 
over a 1 year period covering the period of 6 months prior 
and 6 months after the CCHS interview date. The choice of ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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this time horizon was dictated by two reasons. First, almost 
half of CCHS interviews occurred between April and October 
2001. As such, since the latest fiscal year available for the 
administrative data was April 1, 2001 to March 31, 2002, 
the majority of respondents had less than 1 year of data 
following the interview. In addition, as weight and BMI may 
change over time, estimates of costs over a longer time period 
(eg, 2 years) before or after the date of CCHS interview may 
be misleading.
statistical analyses
Socio-demographic variables, medical characteristics 
and health status were summarized using means, standard 
deviations and frequencies. Due to the multistage stratified 
sampling design of CCHS, Statistics Canada CCHS 
sample weights were applied to ensure that the results were 
representative of the Ontario population. Significant differences 
between each pair of BMI categories were assessed using 
Tukey’s multiple comparison test for continuous variables10 
and a modification of this method for testing for differences 
in proportions between multiple groups.11
Logistic regressions were used to determine the odds 
ratio of having comorbid conditions, taking a medication, 
being hospitalized or having a day surgery. The HUI utility 
data was analyzed with a Tobit model12 as utility data is 
often skewed with a ceiling effect at 1. The cost data was 
modeled using a two-part model,13,14 a commonly used 
approach for the analysis of obesity cost data.4,15–17 This 
type of model is often used to take into account that a 
proportion of the population does not use medical resources 
(eg, no physician visits or hospitalizations in a given period 
of time) and therefore do not incur any costs. In Hurdle 
models, the data is modeled using two processes. First, 
a logistic regression is used to calculate the probability 
of observing a cost. A generalized linear model defined 
by a logarithmic link function with a gamma distribution 
is then used to model the positive costs. To generate the 
expected cost, the probability of having any use and the 
expected cost conditional on use were multiplied together. 
The excess costs of being underweight, overweight or obese 
versus normal-weight were also determined. To exploit the 
richness of the sampling of CCHS 1.1, bootstrap techniques 
were used to generate confidence intervals associated with 
the expected costs and excess costs versus normal-weight 
individuals.4
The covariates included in the regression analyses were 
age, gender, physical activity (active, moderately active, 
and inactive), BMI level (normal-weight, underweight, 
overweight, and obese), personal income, and smoking 
status (current, former or never smoker). These covariates 
were chosen as they were previously used in other similar 
studies4,6 as they are indirectly related to obesity and costs. 
The level of statistical significance was set at 0.05 a priori 
for all statistical tests and regressions. When the number of 
observations per cell was less than 10, the information was 
not reported. Persons with total expenditures exceeding 
the 99th percentile were excluded from the cost analysis to 
reduce the influence of high-cost outliers. The costs analyses 
were conducted for the hospitalizations, day procedures, 
physician costs and for the total combined costs (hospital 
costs + day procedure costs + physician costs or “total 
costs”). To get a better understanding of the structure of the 
total costs, sub-group analyses were conducted per gender 
and age groups.
Results
The sample population for all analyses was based on 28,797 
adult individuals who participated in CCHS 1.1, provided 
consent to data linkage, and who also had a BMI recording 
in the CCHS. More than half of the adult population of 
Ontario was overweight (35%) or obese (17%). The propor-
tion of adults overweight or obese increased with age while 
the proportion of underweight individuals decreased in older 
adults.
socio-demographic characteristics
The mean age of all adults was 45 years (SD: 17.2) and 
almost 30% of the population was 60 years of age and older.   
Statistical differences between all BMI categories were 
observed in terms of age, gender, marital status, ethnicity 
and physically activity status. In terms of education, obese 
individuals were statistically less likely to have a university 
degree compared to normal-weight individuals (29.6% versus 
42.1%, respectively) (Table 1).   Overweight adults had statisti-
cally higher personal and household incomes compared to 
other BMI categories. Table 1 presents the details.
Medical characteristics
Approximately 64% of adults with a normal-weight reported 
being diagnosed with at least one medical condition and 
21% reported three or more medical conditions. Even after 
covariate adjustment, obese individuals were twice as 
likely to have reported three or more physician-diagnosed 
medical conditions compared to normal-weight individuals 
(Table 2). The probability of reporting a medical condition 
also increased with age, being female, being overweight ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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or being a current or former smoker. Obese individuals 
were three to four times more likely to have high blood 
pressure and diabetes than normal-weight individuals 
and twice as likely to report arthritis/rheumatism, urinary 
incontinence or fibromyalgia. Other differences between 
BMI levels were also observed (Table 2). For example, 
underweight individuals were statistically less likely to 
report diabetes, arthritis, and high blood pressure than 
normal-weight adults, and more likely to report bowel 
disorders, emphysema or COPD, chronic fatigue syndrome, 
and epilepsy.
Consistent with the reporting of medical conditions, 
the odds of using blood pressure medications, diuretics, 
or diabetes medications were three times higher among 
obese individuals than normal-weight individuals. Obese 
adults were also twice as likely to use steroids or cardiac 
medications as normal-weight individuals (Table 3). 
Overweight individuals also took more medications than 
normal-weight adults, but to a lesser extent than obese 
adults. Underweight individuals had lower use-patterns of 
  medications for the treatment of conditions such as diabetes 
and hypertension than normal-weight individuals.
health-related quality of life  
and self-reported health
The HUI scores associated with underweight (0.85 ± 0.25) 
and obese individuals (0.83 ± 0.23) were statistically lower 
than normal-weight individuals (0.89 ± 0.19) (Table 4). 
The HUI scores decreased with age for all BMI categories. 
For the 60 and over group, underweight individuals had 
a significantly lower utility than other adults. A Tobit 
regression indicated that increased age, being female, 
being a current or a former smoker, being underweight, 
overweight or obese were significantly associated with a 
decrease in the HUI utility scores while personal income 
and being physically active were significantly associated 
Table 1 socio-demographic characteristics in adults (18 years and older)a
Normal-weight  
n = 11,828
Underweight  
n = 2075
Overweight  
n = 10,033
Obese  
n = 4861
Age (sD) 43.1 (18.1) 39.9 (20.4) 47.5 (16.0) 47.4 (14.5)
  18–39 40.9% 50.7% 29.8% 29.4%
  40–59 32.4% 23.7% 38.3% 42.7%
  60 and over 26.6% 25.6% 31.9% 27.9%
gender
  Male 46.1% 28.3% 58.8% 52.5%
  Female 53.9% 71.7% 41.2% 47.5%
Marital status
  Married and common law (living with partner) 61.0% 51.8% 71.4% 66.9%
    single, never married, and other  
(widowed, separated, divorced)
39.0% 48.2% 28.6% 33.1%
Place of birth
  Born in Canada 67.0% 63.5% 69.9% 74.6%
  Born elsewhere 33.0% 36.5% 30.1% 25.4%
Education
  University degree 42.1% 39.3% 38.5% 29.6%
  no University degree 57.9% 60.7% 61.5% 70.4%
smoking status
  Current smoker 27.5% 30.1% 24.7% 24.2%
  Former smoker 35.2% 29.7% 42.2% 43.5%
  never smoked 37.3% 40.2% 33.1% 32.3%
Physical activity
  Active 22.7% 21.7% 21.1% 13.5%
  Moderate 24.1% 19.5% 23.7% 22.2%
  inactive 53.2% 58.8% 55.2% 64.5%
Working status
  Employed 86.6% 87.9% 84.1% 84.2%
  not employed 13.4% 12.1% 15.9% 15.8%
income
  Total personal income $26,514 $34,614 $40,674 $34,777
  household income $67,903 $62,005 $69,848 $63,134
Notes: aBased on complete data except for education (n = 16,702 out of 28,797) and working status (n = 24,564 out of 28,797); bold indicates statistical significance 
(ie, P , 0.05) compared to normal-weight.ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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with an increase in HUI utility scores. Self-reported health 
status was significantly worse for obese individuals with 
more than 20% of obese adults reporting having fair or 
poor health, compared to 10% for normal-weight adults 
(Table 4). Approximately 15% of obese adults reported a 
deterioration of their health status versus 10% for normal-
weight individuals.
Economic burden associated  
with BMi in adults
Table 5 presents the mean 1 year adjusted costs associ-
ated with hospitalizations, day procedures and physician 
services as well as the stratified analyses for total costs. In 
terms of hospitalizations, obese individuals have statisti-
cally higher annual costs than normal-weight individuals 
($233 versus $166 or a 40% difference). Obese aindividuals 
also have significantly higher physician and total costs (ie, 
combined hospital, day procedure, and physician costs) 
than normal-weight adults (Table 5). No statistical cost 
differences were observed between overweight and normal-
weight individuals or between underweight and normal-
weight individuals even when the total cost analyses were 
stratified by gender and age groups (Table 5). However, 
the total costs among obese men were not statistically 
different from the total costs among normal-weight men, 
while this difference was statistically significant among 
women. Specifically, the results of the hurdle models used 
to estimate the total costs by gender indicated that being 
an obese man compared to a normal-weight man was not 
a significant factor in modeling the first (probability of 
observing a cost) and the second (modeling costs condi-
tional on use) part of the model. In contrast, obese women 
had significantly higher costs than normal-weight women 
once a cost had been incurred. In all regressions by gender, 
age was always a statistically significant variable at any 
stage of the hurdle model (ie, modeling both the prob-
ability of incurring a cost and modeling costs once a cost 
has been incurred) while being physically active statisti-
Table 2 Medical characteristics for adults with a normal BMi level (18 years and older) and odds ratioa (confidence intervals) by 
BMi levels (reference: normal-weight)b
  Normal-weight  
(%)
OR and CIs underweight  
versus normal-weight
OR and CIs overweight  
versus normal-weight
OR and CIs obese 
versus normal-weight
At least 1 medical condition 64.1% 0.92 (0.8, 1.0) 1.2 (1.1, 1.3) 1.8 (1.6, 1.9)
$3 medical conditions 21.1% 1.1 (1.0, 1.2) 1.3 (1.2, 1.4) 2.1 (2.0, 2.3)
Specific medical conditions
  Allergies other than food 28.0% 1.0 (0.9, 1.1) 1.1 (1.0, 1.1) 1.2 (1.1, 1.3)
  Back problems 17.6% 1.0 (0.8, 1.1) 1.2 (1.1, 1.3) 1.5 (1.4, 1.6)
  Arthritis/rheumatism 15.1% 0.8 (0.7, 0.9) 1.3 (1.3, 1.5) 2.2 (2.0, 2.4)
  high blood pressure 9.9% 0.7 (0.5, 0.8) 1.8 (1.7, 2.0) 3.6 (3.3, 4.0)
  Other chronic condition 11.7% 1.0 (0.9, 1.2) 1.1 (1.0, 1.2) 1.3 (1.2, 1.5)
  Migraine 9.4% 1.0 (0.9, 1.2) 1.2 (1.1, 1.3) 1.5 (1.4, 1.7)
  Asthma 9.2% 1.1 (1.0, 1.4) 1.3 (1.1, 1.4) 1.8 (1.6, 2.0)
  Food allergies 7.6% 1.1 (0.9, 1.3) 1.0 (0.9, 1.1) 1.0 (0.9, 1.2)
  heart disease 5.1% 1.0 (0.8, 1.2) 1.2 (1.0, 1.3) 1.7 (1.5, 2.0)
  Thyroid 4.4% 0.9 (0.7, 1.1) 1.3 (1.1, 1.4) 1.7 (1.5, 1.9)
  Diabetes 2.9% 0.6 (0.4, 0.9) 1.8 (1.6, 2.0) 3.8 (3.3, 4.3)
  Cataracts 4.1% 0.9 (0.7, 1.1) 1.1 (1.0, 1.3) 1.3 (1.1, 1.6)
  stomach/intestinal ulcers 2.8% 1.2 (0.9, 1.5) 1.2 (1.0, 1.4) 1.6 (1.4, 1.9)
  Bronchitis 2.4% 1.3 (1.0, 1.6) 1.0 (0.9, 1.2) 2.0 (1.7, 2.3)
  Bowel disorder 2.5% 1.3 (1.0, 1.7) 1.2 (1.0, 1.4) 1.5 (1.2, 1.8)
  Urinary incontinence 2.1% 1.2 (0.9, 1.6) 1.3 (1.1, 1.5) 2.4 (2.0, 2.9)
  Cancer 1.7% 1.0 (0.7, 1.4) 1.0 (0.8, 1.2) 1.2 (0.9, 1.4)
  glaucoma 1.3% 1.2 (0.8, 1.6) 1.1 (0.9, 1.3) 1.1 (0.9, 1.5)
  Fibromyalgia 1.2% 1.0 (0.7, 1.5) 1.4 (1.1, 1.8) 2.3 (1.8, 2.9)
  Emphysema or COPD 1.1% 2.6 (1.8, 3.7) 0.9 (0.7, 1.1) 1.6 (1.2, 2.1)
  Effects of a stroke 1.3% 1.2 (0.8, 1.8) 0.9 (0.7, 1.2) 1.5 (1.2, 2.0)
  Chronic fatigue syndrome 0.9% 1.5 (1.0, 2.3) 1.0 (0.7, 1.3) 1.7 (1.3, 2.4)
  Epilepsy 0.5% 1.8 (1.1, 2.9) 0.8 (0.6, 1.2) 1.6 (1.1, 2.4)
  Alzheimer’s disease 0.3% 1.0 (0.3, 2.9) 0.7 (0.3, 1.3) 0.9 (0.4, 2.0)
  Multiple sclerosis 0.3% 1.7 (0.9, 3.4) 0.5 (0.3, 1.0) 0.7 (0.4, 1.4)
Notes: aAdjusted by age, gender, personal income, physical activity and smoking status; bbased on complete data except for Emphysema or COPD (n = 23,038 out of 28,797 
respondents); bold indicates statistical significance (ie, P , 0.05) compared to normal weight.
Abbreviations: BMI, body mass index; OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease.ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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cally decreased the costs once a cost has been incurred. 
For all BMI categories, physician costs were larger than 
hospitalization costs (Table 5).
Overall, 8% of all adults were hospitalized. When 
compared to the normal-weight group, underweight (OR 1.3; 
CIs: 1.1, 1.6) and obese adults (OR 1.3; CIs: 1.2, 1.5) were 
more likely to be hospitalized after covariate adjustment. 
While increased age and being female also increased the 
probability of being hospitalized, being overweight and per-
sonal income were not significant variables. The second part 
of the hurdle model used for the analysis of hospitalization 
costs indicated that, once hospitalized and after covariate 
adjustment, the expected costs incurred by underweight 
($6,288; SD: $1,326), overweight ($6,035; SD: $1,033) and 
obese ($6,413, SD: $1,002) individuals were not statistically 
different from the costs associated with the normal-weight 
group ($5,846; SD: $1,135). When analyzing the probability 
of having a day procedure or explaining costs conditional on 
use, being obese was a significant variable for the two stages 
of the hurdle model while underweight and overweight were 
Table 3 Percentage of adults with specific medications and odds ratioa (confidence intervals) by BMI levels (reference: normal-weight)
Normal-weight  
(%)
OR and CIs underweight  
versus normal-weight
OR and CIs overweight  
versus normal-weight
OR and CIs obese 
versus normal-weight
Pain relievers 67.9% 0.8 (0.7, 0.9) 1.1 (1.0, 1.2) 1.2 (1.1, 1.4)
Birth control pills 21.3% 1.1 (0.9, 1.3) 0.9 (0.7, 1.0) 0.9 (0.7, 1.1)
Cough/cold 18.0% 0.9 (0.8, 1.1) 1.1 (1.0, 1.2) 1.2 (1.1, 1.4)
Other 15.3% 1.0 (0.9, 1.2) 1.1 (1.0, 1.2) 1.4 (1.3, 1.6)
hormones for menopause 13.9% 0.8 (0.6, 0.9) 1.2 (1.0, 1.3) 1.1 (0.9, 1.3)
Blood pressure 9.4% 0.7 (0.6, 0.8) 1.8 (1.6, 2.0) 3.5 (3.1, 3.9)
stomach 10.4% 1.0 (0.8, 1.1) 1.3 (1.2, 1.4) 1.6 (1.4, 1.8)
Allergy medicine 9.4% 0.9 (0.7, 1.1) 1.0 (0.9, 1.1) 1.1 (1.0, 1.3)
Penicillin/other 8.0% 1.2 (1.0, 1.4) 1.0 (0.9, 1.1) 1.3 (1.1, 1.5)
Asthma medications 5.5% 1.3 (1.1, 1.6) 1.2 (1.1, 1.4) 1.8 (1.6, 2.1)
Codeine/demerol/morphine 5.5% 1.3 (1.1, 1.6) 1.2 (1.1, 1.4) 1.7 (1.4, 1.9)
Medicine for the heart 4.9% 1.0 (0.8, 1.3) 1.2 (1.1, 1.4) 2.0 (1.7, 2.3)
Antidepressants 5.0% 1.0 (0.8, 1.2) 1.2 (1.1, 1.4) 1.8 (1.6, 2.1)
sleeping pills 4.8% 1.3 (1.0, 1.5) 1.0 (0.9, 1.1) 1.1 (0.9, 1.2)
Diuretics 3.6% 0.8 (0.6, 1.1) 1.5 (1.3, 1.7) 3.3 (2.9, 3.9)
Thyroid 4.1% 0.8 (0.6, 1.0) 1.2 (1.0, 1.4) 1.7 (1.4, 1.9)
Laxatives 3.9% 1.1 (0.9, 1.4) 0.9 (0.8, 1.1) 1.1 (0.9, 1.3)
Control diabetes 1.8% 0.4 (0.3, 0.8) 1.8 (1.5, 2.2) 3.7 (3.1, 4.6)
Tranquilizers 2.7% 1.7 (1.3, 2.2) 1.1 (0.9, 1.3) 1.5 (1.2, 1.8)
steroids 1.3% 1.2 (0.8, 1.8) 1.2 (1.0, 1.6) 2.0 (1.6, 2.7)
insulin 0.5% 0.9 (0.5, 1.8) 1.9 (1.4, 2.6) 3.3 (2.4, 4.6)
Note: aAdjusted by age, gender, personal income, physical activity and smoking status; bold indicates statistical significance (ie, P , 0.05) compared to normal weight.
Abbreviations: BMI, body mass index; OR, odds ratio; CI, confidence interval.
Table 4 health-related quality of life for adults (18 years and older)a
Normal-weight Underweight Overweight Obese
Mean (sD) hUi3 utility index 0.89 (0.19) 0.85 (0.25) 0.87 (0.19) 0.83 (0.23)
  18–39 0.91 (0.17) 0.90 (0.19) 0.91 (0.16) 0.89 (0.19)
  40–59 0.88 (0.19) 0.85 (0.24) 0.88 (0.19) 0.82 (0.24)
  60 and over 0.80 (0.22) 0.67 (0.31) 0.80 (0.21) 0.74 (0.24)
self-reported health
  Excellent/very good/good 89.7% 85.8% 87.7% 78.7%
  Fair/poor 10.4% 14.2% 12.3% 21.2%
Compared to one year ago
  Much better/somewhat/about same 89.3% 88.0% 88.3% 84.4%
  somewhat worse/much worse now than 1 year ago 10.7% 11.9% 11.7% 15.6%
Did something to improve health over last year
  Yes 52.5% 48.9% 54.6% 55.5%
  no 47.5% 51.1% 45.4% 44.5%
Notes: aBased on complete data except for the last question “Did something to improve health over the last year” (n = 27,265 out of 28,797 respondents); bold indicates 
statistical significance (ie, P , 0.05) compared to normal-weight. 
Abbreviation: sD, standard deviation.ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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not significant variables when compared to normal weight 
individuals.
Discussion
This study confirms that being obese is associated with a 
negative impact on health and higher health care costs for 
adults in Ontario. Specifically, obese adults were more likely 
to have a lower health-related quality of life (ie, 0.83) than 
normal-weight adults (ie, 0.89). As a reference, a difference 
in the HUI score of 0.05 between two groups is clinically 
significant.9 In addition, obese individuals were more likely 
to report more medical conditions, to take more medications 
and to incur higher costs due to hospitalizations and physi-
cian services. Although being overweight was not associated 
with an increased cost in our analyses, it should be noted that 
many overweight individuals will end up obese. For example, 
Canadian data have shown that almost a quarter of individu-
als who were overweight in 1994/95 had become obese by 
2002/03. In contrast, only 10% of overweight individuals 
in 1994–95 had a normal weight in 2002–03.18 As shown 
by CCHS 1.1, less than half of the Ontario adult population 
reported having a normal BMI in 2000/2001. It is therefore 
important that health systems consider broadly implementing 
programs that target both prevention (eg, in the community, 
school and workplace) as well as obesity treatment (eg, 
interdisciplinary primary care teams, and specialist services 
including bariatric surgery). We also observed no statistical 
significance difference between the total costs of obese and 
normal weight men while this difference was statistically 
significant for women. Two main factors may explain these 
results. In all regressions, women had significantly higher 
physician, day procedure and hospitalization costs than men 
once a cost has been incurred. In addition, women had a 
higher probability of being hospitalized or undergoing a day 
procedure than men. As such, programs targeted towards 
women may have greater potential for reducing costs associ-
ated with hospitalization, day procedures, and physicians. 
Similarly, in light of the magnitude of the cost differences 
between obese and normal weight group in the 40–59 year 
old age group, efforts should be put into targeting middle-
aged obese individuals. In this context, the workplace may be 
a suitable environment for the implementation of programs 
aimed at preventing obesity and its related complications (eg, 
diabetes, hypertension).
Recently two reviews on the burden of obesity have 
been published. The first19 reviewed 32 studies published 
between 1990 and June 2009 which evaluated the direct 
costs associated with obesity. Despite differences in study 
designs, all studies indicated that the financial burden of 
obesity was significant, accounting for between 0.7% and 
Table 5 One year physician, hospitalization, day procedure and total costsa according to BMi categories and cost differences (reference: 
normal-weight) (mean and 95% confidence intervals)b
Normal-weight Underweight Overweight Obese
hospitalisation costs $166.3 ($144.3, $190.3) $206.1 ($150.3, $270.6) $165.2 ($140.0, $190.5) $233.3 ($192.7, $276.3)
  Cost difference Reference group $39.8 (-$22.5, $110.6) -$1.1 (-$35.3, $29.0) $67.0 ($23.5, $114.2)
Day procedure costs $57.6 ($49.9, $66.7) $54.2 ($39.7, $69.1) $60.1 ($53.6, $67.0) $67.3 ($58.1, $76.8)
  Cost difference Reference group -$3.4 (-$18.8, $13.0) $2.5 (-$8.6, $12.9) $9.7 (-$0.9, $20.7)
Physician costs $476.8 ($457.6, $498.4) $487.8 ($447.1, $530.3) $463.4 ($441.8, $487.3) $584.9 ($544.3, $630.8)
  Cost difference Reference group $11.0 (-$34.3, $56.0) -$13.4 (-$43.3, $14.1) $108.1 ($63.9, $155.4)
Total costsa $708.0 ($668.2, $752.4) $746.0 ($652.0, $834.6) $690.3 ($648.2, $736.4) $884.1 ($806.1, $953.8)
  Cost difference Reference group $38.0 (-$57.7, $138.9) -$17.7 (-$74.2, $38.4) $176.1 ($88.3, $252.8)
Total costs: male $600.1 ($543.3, $659.8) $691.3 ($521.6, $911.5) $540.3 ($497.3, $581.5) $671.2 ($585.3, $765.5)
  Cost difference Reference group $91.2 (-$97.4, $312.6) -$59.8 (-$133.4, $14.1) $71.1 (-$36.1, $178.3)
Total costs: female $812.9 ($755.2, $863.3) $821.4 ($710.1, $944.6) $849.4 ($781.6, $932.4) $1121.9 ($1013.4, $1243.5)
  Cost difference Reference group $8.5 (-$105.1, $140.2) $36.5 (-$45.0, $128.3) $309.0 ($185.3, $441.4)
Total costs: 
Young adults (18–39)
$424.3 ($389.2, $460.0) $404.1 ($338.8, $480.5) $436.4 ($394.3, $483.4) $506.3 ($435.1, $586.6)
  Cost difference Reference group -$20.2 (-$87.6, $61.6) $12.1 (-$50.9, $71.4) $82.0 ($2.0, $176.1)
Total costs: 
Middle-age adults (40–59)
$673.4 ($613.9, $745.7) $810.4 ($599.6, $1040.0) $618.7 ($556.7, $685.5) $918.3 ($809.3, $1051.2)
  Cost difference Reference group $137.0 (-$79.1, $382.0) -$54.7 (-$137.7, $33.6) $244.9 ($108.9, $393.1)
Total costs: 
Older adults (60 and +)
$1230.5 ($1123.1, $1348.7) $1201.9 ($975.8, $1462.3) $1282.9 ($1162.9, $1399.0) $1476.1 ($1296.9, $1665.7)
  Cost difference Reference group -$28.6 (-$268.4, $220.1) $52.4 (-$95.1, $177.1) $245.6 ($59.1, $442.3)
Notes:  aTotal  cost  =  hospitalization  costs  +  day  procedure  costs  +  physician  costs;  badjusted  for  personal  income,  smoking  status,  physical  activity  status,  age   
and gender; all values are Canadian dollars; bold indicates statistical significance (ie, P , 0.05) compared to normal weight.ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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2.8% of healthcare expenditures. This review also reported 
that the costs associated with obesity were estimated to be 
30% higher than that of normal-weight individuals, which 
is consistent with our analyses (24% for the total costs). 
Another recent review focussed on the direct medical cost 
of being overweight and obese in the US, based on 33 US 
studies published up to September 2009. Depending on which 
studies were included, the per-person excess costs associated 
with overweight ranged from $298 to $498 when compared 
to normal-weight BMI. In comparison, the incremental cost 
of obesity was estimated to range from $1630 to $1723. 
Based on these figures, the authors estimated that the direct 
medical cost of overweight and obesity accounted for almost 
5% of the total US health expenditure, which is comparable 
to the most recent Canadian estimate (4.1%).1 Although these 
two reviews provide invaluable information, it is difficult to 
directly compare the results of these studies with our study. 
With the exception of Janssen et al4 and Finkelstein20, no stud-
ies have been conducted in Canada using population survey 
data linked to patient-level administrative data.
The interpretation of our results was similar to 
  Janssen et al4 despite the fact that we also analyzed hospital 
and day procedure costs. Specifically, the annual physician 
costs reported in our study were similar to those reported by 
Janssen et al4 even if Janssen et al used two years of fiscal 
data (2002 and 2003) to calculate an average physician cost 
per year while we used one year of data (ie, 6 months before 
and 6 months after the date of interview). Nonetheless, other 
calculations (data not shown) indicated that the physician 
costs associated with normal-weight and obese males in our 
study were $408 and $456, respectively, compared to $414 
and $475 in Janssen’s study. For women, the figures in our 
study were $549 (normal-weight) and $726 (obese), which 
compared to $577 and $682 in Janssen’s study.4 Our analyses 
indicated that compared to normal-weight individuals, being 
overweight was not associated with a significant increase in 
hospitalization and day procedures costs. This finding was 
also observed by Janssen et al4 in their analysis of physician 
costs, and reported in a recent review of the direct costs of 
overweight and obesity in the US.21
Although an earlier record linkage conducted in Ontario 
calculated the additional physician costs for each unit 
increase in BMI at $8.90, no information was provided on 
the physician costs per BMI category20 and therefore cannot 
be used to compare our results.
There are several limitations with our study that have 
to be considered when interpreting the results. First, the 
true costs associated with BMI categories are likely to 
be underestimated as drug costs, costs associated with other 
non-physician healthcare providers or indirect costs were not 
included as they were unavailable for analysis. Secondly, as 
found in several studies using surveys from Statistics Canada 
(eg, CCHS 1.1),4–7 individuals were classified according to 
self-reported BMI which may have introduced some bias 
in our estimates. Although other prevalence-based cost-of-
illness studies have used measured BMI data from CCHS 
2004,1,22 CCHS 1.1 was at the time of analysis the most recent 
CCHS data that could be linked with administrative databases 
at our Research Data Center. Nonetheless, the use of self-
reported BMI may have introduced some bias in our estimate 
of the burden of obesity. As a reference, the measured 
prevalence of obesity in Canada was found to be 7% higher 
than the self-reported prevalence based on data from the 
2005 CCHS in which height and weight were   measured for 
a sub-sample of the survey.23 Differences of -8.5 BMI points 
(CI: -10.0 to -7.1) and of 7.4 BMI points (CI: 6.0 to 8.8) 
between measured and self-reported BMI were reported for 
the normal and obese population, respectively. The sensitivity 
and specificity between self-reported and measured BMI 
for normal-weight people were 93% (CI: 90–95) and 79% 
(CI: 75–82), respectively. Sensitivity was lower for obese 
  individuals (63%) but the specificity was high (more than 
95%). Since very few respondents would report weight and 
height that would categorize them as being obese unless 
they were actually obese, our cost estimates for the obese 
population should closely reflect the costs associated with 
measured obesity. As such, the cost differences between 
the obese and normal-weight populations should also be 
reflective of the differences between these two categories 
based on measured BMI. Although numerical differences 
existed between measured versus self-reported BMI 
prevalence rates for the overweight category (ie, 1.9 BMI 
points), these differences were not statistically significant. 
In addition, our analyses did not show any   statistically 
significant cost differences between normal-weight and 
overweight individuals. The interpretation of the results on 
quality of life associated with the BMI categories should 
not be impacted by the self-reported BMI as no statistically 
significant differences were observed in terms of activity 
limitation and self-perceived health when measured and self-
reported BMI were compared.24 The most recent Canadian 
data25 indicates that 26.1% and 23.3% of Canadian men and 
women were obese in 2008 after correcting for bias in self-
reported estimates of BMI. In contrast, the proportions of 
obese men and women were respectively 18.5% and 16.1% 
in 2008 when using self-reported values, which was close ClinicoEconomics and Outcomes Research 2012:4 submit your manuscript | www.dovepress.com
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to the CCHS 1.1 estimates (17% of Ontarians estimated as 
obese). As such the costs that were reported in our study are 
probably higher.
Another important limitation is that BMI does not 
truly reflect the burden of obesity-related health risks. 
Thus, as recently demonstrated in several large US popula-
tion samples,26,27 the Edmonton Obesity Staging System 
(EOSS), which classified overweight and obese individuals 
on a 5-point ordinal scale based on the presence of medical, 
mental and/or functional comorbidities, strongly predicted 
mortality, whereas BMI did not. Importantly, in this analysis, 
a considerable proportion (about 50%) of individuals in 
the overweight range presented with obesity-related health 
problems (EOSS $1), while a substantial number (about 
30%) of individuals with BMI .30 had no obesity-related 
health risks. Thus, our current analysis may underestimate the 
true health cost of excess weight to the health system.
Since we did not have access to drug claims data, we 
were not able to estimate drug costs per BMI category, 
which is an important limitation of our study. Although our 
  analyses using the survey data indicated that excess weight 
was associated with an increase use of drugs, we were not 
able to estimate this cost. Our sample of respondents excluded 
respondents living in long-term care facilities, nursing homes 
or the armed forces. Finally, the data is almost ten years old 
and although the prevalence of obesity has increased over 
time, it is unknown whether the associations between obesity, 
its health outcomes and costs have changed over the last 
10 years. Linking longitudinal population health surveys with 
several years of administrative data is an important avenue 
for future research.
Despite these limitations, this work helps to better 
understand the burden associated with BMI categories 
in Canada. In particular, it provides new and previously 
unavailable information on the costs associated with 
hospitalizations and day procedures per BMI category as 
well as new data on underweight adults (eg, HRQoL and 
costs). By exploiting the richness of survey data linked to 
administrative databases (using BMI from CCHS to calculate 
cost per BMI category using administrative database), the 
results emphasize the tremendous human and economic 
burden of underweight and obesity in Ontario. The data gener-
ated in this study, including costs and utilities per BMI level, 
can also be used to evaluate strategies aimed at decreasing 
or containing the burden of under- and excess-weight in 
Canada. Several authors of this paper have contributed to 
the development of the Ontario Diabetes Economic Model 
(ODEM) based on the United Kingdom Prospective Diabetes 
Study combined with resource utilization, utilities and costs 
from Ontario. The ODEM is currently used by the Ontario 
Ministry of Health and Long-Term Care to evaluate diabetes 
  management strategies.28 To better inform decision makers 
about the value of programs aimed at managing the burden 
of under and excess weight, the development of an obesity 
policy model is an important area of future research.
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